Table 1.
None | Antipsychotic | Sedative-Hypnotic | Antidepressant | Mood Stabilizer | |
---|---|---|---|---|---|
Participants, n | 234 | 56 | 70 | 103 | 13 |
Overall weighted percent (95% CI) | 58.6 (52.4–64.6) | 10.9 (7.6–15.3) | 19.5 (14.2–26.2) | 23.5 (18.8–29.0) | 1.5 (0.9–2.7) |
Population estimate, millions (95% CIb) | 3.9 (3.0–4.8) | 0.7 (0.5–1.0) | 1.3 (0.8–1.9) | 1.6 (1.1–2.0) | 0.1 (0.05–0.2) |
n (column weighted percent [95% CI]) | |||||
Reside in nursing home | 33 (6.3 [4.2–9.4]) | 32 (65.3 [49.1–78.6)] | 33 (53.1 [31.3–73.7]) | 44 (52.7 [34.6–70.1]) | 6 (39.7 [18.3–65.9]) |
Dementia stagec | |||||
Mild | 170 (84.7 [75.8–90.8]) | 11 (23.6 [7.9–52.6]) | 29 (59.0 [40.8–74.9]) | 52 (49.0 [34.8–63.4]) | 3 (32.6 [12.3–62.5]) |
Moderate | 24 (6.5 [3.2–12.8)] | 19 (36.4 [16.8–61.9]) | 23 (27.6 [14.4–46.3]) | 26 (24.1 [12.8–40.6]) | 4 (34.5 [13.5–63.9]) |
Severe | 39 (8.8 [4.8–15.4)] | 26 (40.0 [24.8–57.3]) | 18 (13.5 [6.0–27.4]) | 25 (26.9 [14.2–45.0]) | 6 (33.0 [12.0–63.9]) |
Cholinesterase Inhibitor or memantine | 29 (14.1 [7.2–26.9]) | 18 (38.4 [18.3–63.3]) | 12 (17.8 [7.8–35.7]) | 23 (34.4 [19.0–54.0]) | 4 (30.3 [9.6–64.0]) |
Other Psychotropic Medication | |||||
Antipsychotic | n/ad | n/a | 16 (20.0 [9.1–38.5]) | 20 (20.5 [10.1–37.0]) | 7 (37.0 [17.0–62.7]) |
Sedative-hypnotic | n/a | 16 (35.8 [16.1–62.0]) | n/a | 20 (26.1 [14.4–42.6]) | 6 (43.1 [12.8–79.6]) |
Antidepressant | n/a | 20 (44.2 [22.0–69.0]) | 20 (31.4 [17.0–50.6]) | n/a | 8 (47.8 [24.9–71.7]) |
Mood Stabilizer | n/a | 7 (5.2 [2.1–12.5]) | 6 (3.4 [1.0–10.4]) | 8 (3.1 [1.3–7.4]) | n/a |
Any | n/a | 32 (65.1 [42.9–82.3]) | 37 (44.3 [28.1–61.9]) | 43 (44.7 [29.3–61.3]) | 12 (82.4 [28.3–98.2]) |
Medication groups are not mutually exclusive
CI: confidence interval
As classified by Clinical Dementia Rating Scale (CDR) Score: Mild (CDR 0.5–1.0); Moderate (CDR 2.0); Severe (CDR 3.0–5.0)
n/a: not applicable